Resverlogix Corp (RVX) Common NPV

Sell:0.10 CADBuy:0.11 CADPrice unchangedNo change

Prices delayed by at least 15 minutes
Sell:0.10 CAD
Buy:0.11 CAD
Change:Price unchangedNo change
Deal now
Prices delayed by at least 15 minutes
Sell:0.10 CAD
Buy:0.11 CAD
Change:Price unchangedNo change
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open0.10 CAD
Previous close0.10 CAD
Market capCA$31.64m
P/E ratio-
Volume3,500
Dividend yield0.00%
EMS-

Company information

Resverlogix Corp. is a Canada-based late-stage clinical biotechnology company dedicated to improving the lives of patients with chronic illnesses. The Company focuses on the development of a new class of therapeutics: ...

  • LocationCanada
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyCAD
  • Shares in issue316.17m
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share -
  • Ex-dividend date -
  • Payment date -

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.